Pazopanib for the treatment of metastatic renal cell carcinoma

Clinical Therapeutics
Amy M Pick, Kelly K Nystrom

Abstract

Renal cell carcinoma (RCC) is the most common cancer in the kidneys. Until 2005, treatment options were limited to immunotherapy. Since that time, there have been numerous targeted therapy agents approved with improved efficacy toward RCC. Pazopanib is a multi-tyrosine kinase inhibitor that was approved by the US Food and Drug Administration in October 2009 and by the European Medicines Agency in June 2010 for the treatment of metastatic RCC. The objective of this report was to review pazopanib's mechanism of action; pharmacologic, pharmacokinetic, and dynamic properties; potential drug interactions; and the results of clinical trials evaluating efficacy and tolerability associated with pazopanib for the treatment of RCC. MEDLINE, International Pharmaceutical Abstracts, and Web of Science were searched for English-only clinical trials and therapeutic reviews (publication dates: 2000-January 1, 2012). Abstracts from the 2000 to 2011 meetings of the American Society of Clinical Oncology were searched for an updated safety profile and tolerability data of pazopanib in RCC. References from relevant articles were reviewed. Key search terms included pazopanib, Votrient, GW786034, renal cell carcinoma, adverse events, pharmacology, ph...Continue Reading

References

Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward M MessingUNKNOWN Eastern Cooperative Oncology Group/Intergroup trial
Jun 18, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph I ClarkKim A Margolin
May 10, 2005·Diagnostic Cytopathology·Maria Sironi, Gianni Tunesi
Feb 10, 2007·Current Oncology Reports·Guru Sonpavde, Thomas E Hutson
Aug 12, 2008·Current Cancer Drug Targets·Georgios Lainakis, Aristotle Bamias
Apr 4, 2009·Cancer Chemotherapy and Pharmacology·David J Reeves, Chin Y Liu
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Herbert I HurwitzLini Pandite
Dec 4, 2009·Expert Opinion on Pharmacotherapy·Suwicha Limvorasak, Edwin M Posadas
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E HutsonRobert A Figlin
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 2, 2013·Angiogenesis·E M ProkopiouJ J Walsh
Aug 9, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Ravaud, M Schmidinger
Nov 1, 2014·Thoracic Cancer·Hong-Lin ZhaoQing-Hua Zhou
Apr 23, 2016·Clinical Genitourinary Cancer·Satoshi NodaTomohiro Terada
Mar 31, 2015·Cancer Treatment Reviews·Maikel HerbrinkJos H Beijnen
Aug 30, 2016·Seminars in Cell & Developmental Biology·A Marcell SzászGyörgy Marko-Varga
Nov 9, 2016·Clinical Sarcoma Research·Astrid LipplaaHans Gelderblom
Jan 6, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Li-Tzong ChenYoon-Koo Kang
Apr 12, 2017·Antioxidants & Redox Signaling·Carlo Gabriele TocchettiGiuseppe Mercuro
Feb 3, 2016·Therapeutic Advances in Urology·David Cella, Jennifer L Beaumont
May 19, 2018·International Journal of Molecular Sciences·Beata ŻołnowskaJarosław Chojnacki
Nov 30, 2019·British Journal of Clinical Pharmacology·Kim WesterdijkUNKNOWN Dutch Pharmacology and Oncology Group (DPOG)
Jul 12, 2018·BioMed Research International·Claudia ArenaLorenzo Lo Muzio
Nov 28, 2018·BMC Pharmacology & Toxicology·María José Méndez-VidalEnrique Gallardo
Jul 6, 2017·Pharmacogenetics and Genomics·Caroline F ThornTeri E Klein
Feb 27, 2021·Chemical Communications : Chem Comm·Xiong ChenJinlan Zhang
Nov 27, 2020·Experimental Animals·Baran AkagunduzHalis Suleyman
Aug 28, 2021·European Journal of Medicinal Chemistry·Osama M SoltanMohamed Abdel-Aziz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Related Papers

Expert Opinion on Investigational Drugs
Laleh Amiri-KordestaniSandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bernard EscudierVesna Sneller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Laurence AlbigesBernard Escudier
© 2022 Meta ULC. All rights reserved